The Enterprise Value as of November 2024 (TTM) for Acurx Pharmaceuticals, Inc. (ACXP) is 17.04M

According to Acurx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.04M. This represents a change of -44.70% compared to the average of 30.82M of the last 4 quarters.

Acurx Pharmaceuticals, Inc. (ACXP) Historical Enterprise Value (quarterly & annually)

How has ACXP Enterprise Value performed in the past?

The mean historical Enterprise Value of Acurx Pharmaceuticals, Inc. over the last ten years is 51.41M. The current 17.04M Enterprise Value has changed 3.21% with respect to the historical average. Over the past ten years (40 quarters), ACXP's Enterprise Value was at its highest in in the March 2020 quarter at 77.76M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Acurx Pharmaceuticals, Inc. (ACXP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acurx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acurx Pharmaceuticals, Inc. (ACXP) Average Enterprise Value

How has ACXP Enterprise Value performed in the past?

The current Enterprise Value of Acurx Pharmaceuticals, Inc. (ACXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acurx Pharmaceuticals, Inc. (ACXP) Enterprise Value vs. Peers

How is ACXP’s Enterprise Value compared to its peers?

Acurx Pharmaceuticals, Inc.’s Enterprise Value is less than Aerovate Therapeutics, Inc. (46.23M), less than Adagene Inc. (22.22M), less than Acrivon Therapeutics, Inc. Common Stock (163.47M), less than Rezolute, Inc. (276.11M), greater than AN2 Therapeutics, Inc. (6.48M), less than Anebulo Pharmaceuticals, Inc. (36.46M), less than Mineralys Therapeutics, Inc. (523.81M), greater than Silo Pharma, Inc. (-1004254.00), greater than Protagenic Therapeutics, Inc. (3.36M), less than Lumos Pharma, Inc. (23.89M), less than Candel Therapeutics, Inc. (163.14M), less than PMV Pharmaceuticals, Inc. (47.77M), less than Monopar Therapeutics Inc. (100.06M), less than Enochian Biosciences, Inc. (85.97M),

Build a custom stock screener for Acurx Pharmaceuticals, Inc. (ACXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acurx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acurx Pharmaceuticals, Inc. (ACXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acurx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.